Skip to main content

Peer Review reports

From: Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer

Original Submission
24 Jun 2017 Submitted Original manuscript
22 Aug 2017 Reviewed Reviewer Report - YINKA ADOJUTELEGAN
23 Aug 2017 Reviewed Reviewer Report - Chaisiri Angkurawaranon
28 Aug 2017 Reviewed Reviewer Report - Cecily Banura
2 Sep 2017 Author responded Author comments - Chimezie Anyakora
Resubmission - Version 2
2 Sep 2017 Submitted Manuscript version 2
6 Sep 2017 Author responded Author comments - Chimezie Anyakora
Resubmission - Version 3
6 Sep 2017 Submitted Manuscript version 3
Publishing
8 Sep 2017 Editorially accepted
18 Sep 2017 Article published 10.1186/s12913-017-2610-8

You can find further information about peer review here.

Back to article page